The report entitled The Plasma Proteins Market in the Middle East & Africa 2022 provides sales in units and dollars of all the therapeutic plasma and recombinant proteins by company for 23 total countries in Middle East & Africa. It covers complete historical sales of 2022 and some events in 2023 and was completed in the fall of 2023. These countries included are:

Algeria, Bahrain, Botswana, Egypt, Iran, Iraq, Israel, Jordan, Kenya Kuwait, Lebanon, Lesotho, Namibia, Oman, Qatar, Saudi Arabia, South Africa, Syria, Tanzania, Tunisia, Turkiye, Uganda and United Arab Emirates.

This report is updated every three years and has historical data from 2013, 2016 and 2019 for analyzing recent growth trajectories.

As in previous reports, the sales data in this region largely reflect the results of public tenders, and in a few countries sales of the smaller but growing private markets. The report also analyses products distribution and pricing, blood and plasma collections, plasma fractionation, hemophilia care and new product introductions.

The report is delivered electronically (Excel and pdf files) and as a hard copy. Each country chapter covers the topics listed in the table of contents of a sample country chapter below.

For more information or to order this report, please contact
The Marketing Research Bureau at info@marketingresearchbureau.com, or +1 425 502 6265.